Insulin-treated diabetes in dependent or institutionalized patients is often poorly balanced and continuous glucose measurement is underused. The purpose of this tudy is to know how smart connected insulin pens and continuous glucose measurement can improve insulin therapy practice in dependent and/or institutionalized patients?
Insulin-treated diabetes in dependent or institutionalized patients is often poorly balanced and continuous glucose measurement is underused. Current practice and my experience in diabetes show a misuse of insulin therapy by caregivers at home and in institutions. Studies on the elderly insulin-treated person living in institutions show, through continuous glucose measurement, frequent nocturnal hypoglycemia at 79%. The continuous measurement of glucose has also shown its interest in reducing hospitalizations for acute event and, permanently. A norwegian study shows that hypoglycemic treatments are too frequently prescribed in nursing homes. Hospitalizations for severe hypoglycemia are often due to dose errors or unsupervised recommendations in people over 65 years. Smart connected insulin pens have shown a benefit in the management of insulin therapy in patients living with type 1 diabetes, improving glycemic balance. Study focuses on the identification of misuses of insulin therapy in dependent and/or institutionalized patients. A study of everyday life, we expect a decrease in dysfunctions in patients equipped with a continuous glucose measurement system and connected pens after advice given to their caregivers.
Study Type
OBSERVATIONAL
Enrollment
30
Advice on the proper use of insulin therapy will be given, if necessary, to caregivers. Patients are reviewed at 1 month of this first visit with a collection of the same data
Centre Hospitalier Sud Francilien
Corbeil-Essonnes, France, France
RECRUITINGInsulin Injection
Percentage of insulin injections not as prescribed
Time frame: at day 0
number of missed injections
Percentage of missed injections
Time frame: at day 0
number of injections
Percentage of injections performed with a dose deviation of +-20% from the prescribed dose
Time frame: at day 0
number of injections
Percentage of injections performed outside the meal time : more than 15 minutes before or more than an hour after the meal.
Time frame: at day 0
Continuous glucose measurement parameters
Time in range
Time frame: at day 0
Continuous glucose measurement parameters
Time in range
Time frame: at day 30
Acute Diabetes Events
severe hypoglycemia, hyperglycemia requiring hospitalization
Time frame: at day 0
Acute Diabetes Events
severe hypoglycemia, hyperglycemia requiring hospitalization
Time frame: at day 30
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.